Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic developments in peroxisome biogenesis disorders.

M C McGuinness1, H Wei, K D Smith

  • 1Kennedy Krieger Institute, Room 400A, 707 North Broadway, Baltimore, MD 21205, USA. smithk@welchlink.welch.jhu.edu

Expert Opinion on Investigational Drugs
|November 4, 2000
PubMed
Summary

Peroxisome biogenesis disorders (PBDs) are severe genetic diseases. Sodium 4-phenylbutyrate shows promise in improving biochemical functions in milder PBD patient cell lines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for new phenomena with the <math></math> variable in the all-hadronic final state produced in proton-proton collisions at <math> </math> <math></math>.

The European physical journal. C, Particles and fields·2020
Same author

Search for dark matter produced in association with heavy-flavor quark pairs in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2020
Same author

Extraction and validation of a new set of CMS pythia8 tunes from underlying-event measurements.

The European physical journal. C, Particles and fields·2020
Same author

Search for Physics beyond the Standard Model in Events with Overlapping Photons and Jets.

Physical review letters·2020
Same author

Measurements of triple-differential cross sections for inclusive isolated-photon+jet events in <math></math> collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019
Same author

Measurement of the average very forward energy as a function of the track multiplicity at central pseudorapidities in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Peroxisome biogenesis disorders (PBDs) encompass a spectrum of severe genetic conditions, including Zellweger syndrome and infantile Refsum disease.
  • PBDs are characterized by metabolic dysfunction, affecting peroxide degradation, fatty acid metabolism, and synthesis of vital lipids like plasmalogens and bile acids.
  • Current treatments for PBDs are limited to supportive and symptomatic care, with significant challenges in addressing severe congenital neurological alterations.

Purpose of the Study:

  • To review current and emerging treatment strategies for peroxisome biogenesis disorders (PBDs).
  • To evaluate the potential of dietary interventions and pharmacological approaches for PBD management.
  • To explore the efficacy of inducing peroxisome proliferation as a therapeutic avenue for PBD patients.

Related Experiment Videos

Main Methods:

  • Review of existing literature on PBD treatments, including dietary supplementation and pharmacological induction of peroxisomes.
  • Analysis of experimental therapies targeting biochemical abnormalities in PBDs.
  • Investigation into the effects of sodium 4-phenylbutyrate on peroxisome function in patient-derived fibroblast cell lines.

Main Results:

  • Rodent peroxisomal proliferators were ineffective in inducing human peroxisomes.
  • Sodium 4-phenylbutyrate demonstrated the ability to induce peroxisome proliferation in fibroblast cell lines from patients with milder PBD phenotypes.
  • This induction led to improved biochemical functions, including enhanced very long chain fatty acid beta-oxidation and normalized very long chain fatty acid and plasmalogen levels.

Conclusions:

  • Dietary modification and pharmacological induction of peroxisomes represent promising therapeutic strategies for PBDs.
  • Sodium 4-phenylbutyrate shows potential for improving peroxisomal function in milder PBD cases.
  • Further research is warranted to translate these findings into clinical benefits for PBD patients.